Egispas 20mg/250mg Tablet

Quick info

Egispas 20mg/250mg Tablet is a prescription medicine that helps to provide symptomatic relief from menstrual pain and cramps, and treats abdominal pain by relieving muscle spasms in the stomach and intestines. Egispas 20mg/250mg Tablet should be taken with food to prevent an upset stomach. The dose and duration depend on the condition being treated and symptom relief. Common side effects include dizziness, dry mouth, blurred vision, nausea, and sleepiness. Consult your doctor if side effects persist or worsen. Inform your doctor about any kidney or liver problems or other medications you are taking. Pregnant and breastfeeding women should seek medical advice before using this medicine.

How it works

Egispas 20mg/250mg Tablet is a combination of Dicyclomine and Mefenamic Acid. Dicyclomine is an anticholinergic that relaxes the muscles in the stomach and gut, stopping sudden muscle contractions and relieving cramps, pain, bloating, and discomfort. Mefenamic Acid is a non-steroidal anti-inflammatory drug (NSAID) that blocks the release of certain chemical messengers causing abdominal pain and inflammation.

Direction of use

Take this medicine in the dose and duration as advised by your doctor. Swallow it whole without chewing, crushing, or breaking it. Egispas 20mg/250mg Tablet should be taken with food.

Tips

• You have been prescribed Egispas 20mg/250mg Tablet to relieve menstrual pain (cramps) and abdominal pain.
• Egispas 20mg/250mg Tablet should preferably be taken with food.
• If you get diarrhea while taking this medicine, stop taking it and consult your doctor.
• Dry mouth may occur as a side effect. Frequent mouth rinses, good oral hygiene, increased water intake, and sugarless candy may help.
• It may cause dizziness, drowsiness, or visual disturbances. Use caution while driving or doing anything that requires concentration.
• Avoid consuming alcohol while taking Egispas 20mg/250mg Tablet as it can cause excessive drowsiness and increase your risk of stomach problems.